Ketamine-induced cholangiopathy in ARDS patients
Authors:
- 27 July 2021
- journal article
- letter
- Published by Springer Nature in Intensive Care Medicine
- Vol. 47 (10) , 1173-1174
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patientsIntensive Care Medicine, 2021
- Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID‐19Liver International, 2021
- Intravenous ketamine and progressive cholangiopathy in COVID-19 patientsJournal of Hepatology, 2021
- Analgesia and sedation in patients with ARDSIntensive Care Medicine, 2020